Male Reproductive System Carcinoma — Trials

Male Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 451
Recruiting: 240
Ph III recruiting: 20
Growth YoY: +1.3%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (190)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06024772	Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer	not yet recruiting	Phase 3	300	Thomas Jefferson UniversityOTHER	2	Aug 25, 2026	clinicaltrials
NCT07641855	A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer	not yet recruiting	Phase 2 / Phase 3	180	Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY	1	Jul 23, 2026	clinicaltrials